UroGen Pharma Ltd. (URGN) Gross margin 2016–2025
UroGen Pharma Ltd. (URGN) gross margin by fiscal year — reported gross profit divided by reported revenue.
88.7%FY2025 · since FY2016: 99.8% → 88.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 88.7% | -1.5 pp |
| FY2024 | 90.2% | +1.5 pp |
| FY2023 | 88.7% | +0.6 pp |
| FY2022 | 88.1% | -1.2 pp |
| FY2021 | 89.3% | -2.2 pp |
| FY2020 | 91.4% | -8.6 pp |
| FY2019 | 100.0% | +159.8 pp |
| FY2018 | -59.8% | -152.5 pp |
| FY2017 | 92.6% | -7.2 pp |
| FY2016 | 99.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice